Tislelizumab (tisle) Combined With/without Gemcitabine and Cisplatin (GC) As Adjuvant Therapy in Patients at High Risk after Upper Urothelial Carcinoma (UTUC) Surgery: A Realworld Study
JOURNAL OF CLINICAL ONCOLOGY（2023）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要